Change in calcium‐phosphorus product mg(2)/dL(2) · patients with bone disease in children with chronic kidney disease
1 finding from 1 review
Quality of sleep · people with CKD
It is very uncertain whether summary of findings: acupressure changes sleep quality PSQI (median compared with control (very low certainty).
1 finding from 1 review
Sleep onset latency ‐ not reported · people with CKD
Summary of findings: acupressure showed no clear difference in sleep latency PSQI (median compared with control (moderate certainty).
1 finding from 1 review
Quality of life · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Anxiety · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Fatigue · people with CKD
Summary of findings: acupressure showed no clear difference in fatigue PIPER Fatigue Scale (PSF) (median compared with control (moderate certainty).
1 finding from 1 review
Hospital admissions · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death · chronic non‐hypovolaemic hypotonic hyponatraemia
It is very uncertain whether vasopressin receptor antagonists changes death compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Health‐related quality of life ( · chronic non‐hypovolaemic hypotonic hyponatraemia
1 finding from 1 review
Length of hospital stay · chronic non‐hypovolaemic hypotonic hyponatraemia
1 finding from 1 review
Cognitive function · chronic non‐hypovolaemic hypotonic hyponatraemia
1 finding from 1 review
Change from baseline in serum sodium concentration · chronic non‐hypovolaemic hypotonic hyponatraemia
1 finding from 1 review
Serum sodium concentration (response) · chronic non‐hypovolaemic hypotonic hyponatraemia
Vasopressin receptor antagonists probably leads to higher serum sodium concentration (response) compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Rapid sodium increase · chronic non‐hypovolaemic hypotonic hyponatraemia
Vasopressin receptor antagonists probably leads to higher rapid sodium increase compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Death · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
End‐of‐treatment response · patients on HD with HCV infection
Direct antivirals (grazoprevir and elbasvir) may leads to higher end‐of‐treatment response compared with placebo (low certainty).
1 finding from 1 review
Sustained virological response · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment discontinuation · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · patients on HD with HCV infection
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found